# Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC

> **NCT03430128** · NA · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 70 (actual)

## Conditions studied

- Peritoneal Metastases

## Interventions

- **DIETARY_SUPPLEMENT:** IMPACT immunotherapy
- **DIETARY_SUPPLEMENT:** ENSURE

## Key facts

- **NCT ID:** NCT03430128
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-23
- **Primary completion:** 2019-01-22
- **Final completion:** 2019-01-22
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430128, "Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03430128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
